NEW YORK (GenomeWeb News) – ChondroGene today said it has received “conditional approval” from Canadian regulators to list its common shares on the Toronto Stock Exchange.
 
The company, which must still file final documentation, said it expects to begin trading its common shares on the TSX by Oct. 31.
 
At that time ChondroGene will change its name to GeneNews and will trade under the symbol GEN, and ChondroGene’s common shares will cease trading on the TSX Venture Exchange.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.